RCKT
Rocket Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.73
-0.19 ▼ -3.86%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$4.81
+0.08 ▲ +1.69%
| Index | RUT | P/E | - | EPS (ttm) | -2.01 | Insider Own | 6.99% | Shs Outstand | 0.11B | Perf Week | 7.26% |
| Market Cap | 0.51B | Forward P/E | - | EPS next Y | 20.74% | Insider Trans | -0.88% | Shs Float | 0.10B | Perf Month | 45.99% |
| Enterprise Value | 0.35B | PEG | - | EPS next Q | -0.4 | Inst Own | 83.18% | Short Float | 13.85% | Perf Quarter | 30.3% |
| Income | -0.22B | P/S | - | EPS this Y | 25.3% | Inst Trans | -4.84% | Short Ratio | 5.78 | Perf Half Y | 44.21% |
| Sales | 0.00B | P/B | 1.85 | EPS next 5Y | 23.69% | ROA | -52% | Short Interest | 13.99M | Perf YTD | 34.76% |
| Book/sh | 2.56 | P/C | 2.72 | EPS past 3/5Y | 14.88% 4.46% | ROE | -60.27% | 52W High | -46.79% ($8.89) | Perf Year | -44.35% |
| Cash/sh | 1.74 | P/FCF | - | Sales past 3/5Y | - | ROIC | -74.58% | 52W Low | 115.98% ($2.19) | Perf 3Y | -75.49% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 26.48% | Gross Margin | - | Volatility(W/M) | 9.91% 8.55% | Perf 5Y | -91.18% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.36 | Perf 10Y | -82.79% |
| Dividend Ex-Date | - | Quick Ratio | 6.38 | EPS Q/Q | 38.49% | Profit Margin | - | RSI (14) | 58.13 | Recom | 2.54 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.38 | Sales Q/Q | - | SMA20 | 7.11% ($4.42) | Beta | 0.44 | Target Price | $8.22 |
| Payout | - | Debt/Eq | 0.09 | Earnings | 2000000 | SMA50 | 21.49% ($3.89) | Rel Volume | 0.75 | Prev Close | $4.92 |
| Employees | 202 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | 14.18% - | SMA200 | 39.96% ($3.38) | Avg Volume(3M) | 2.42M | Price | $4.73 |
| IPO | 2015/2/18 | Option/Short | Yes/Yes | Trades | 9722 | Volume | 1,826,959 | Change | -3.86% |
뉴스 로딩 중...